<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with OASIS Tables with MathML3 v1.1 20151215//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-archive-oasis-article1-mathml3.dtd?>
<?SourceDTD.Version 1.1?>
<?ConverterInfo.XSLTName jpoasis-nisons2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">J Cell Mol Med</journal-id>
    <journal-id journal-id-type="iso-abbrev">J. Cell. Mol. Med</journal-id>
    <journal-id journal-id-type="doi">10.1111/(ISSN)1582-4934</journal-id>
    <journal-id journal-id-type="publisher-id">JCMM</journal-id>
    <journal-title-group>
      <journal-title>Journal of Cellular and Molecular Medicine</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">1582-1838</issn>
    <issn pub-type="epub">1582-4934</issn>
    <publisher>
      <publisher-name>John Wiley and Sons Inc.</publisher-name>
      <publisher-loc>Hoboken</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">7417703</article-id>
    <article-id pub-id-type="doi">10.1111/jcmm.15618</article-id>
    <article-id pub-id-type="publisher-id">JCMM15618</article-id>
    <article-categories>
      <subj-group subj-group-type="overline">
        <subject>Original Article</subject>
      </subj-group>
      <subj-group subj-group-type="heading">
        <subject>Original Articles</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>A transcriptomic study for identifying cardia‐ and non–cardia‐specific gastric cancer prognostic factors using genetic algorithm‐based methods</article-title>
      <alt-title alt-title-type="left-running-head">XIN et al.</alt-title>
    </title-group>
    <contrib-group>
      <contrib id="jcmm15618-cr-0001" contrib-type="author">
        <name>
          <surname>Xin</surname>
          <given-names>Junyi</given-names>
        </name>
        <xref ref-type="aff" rid="jcmm15618-aff-0001">
          <sup>1</sup>
        </xref>
        <xref ref-type="aff" rid="jcmm15618-aff-0002">
          <sup>2</sup>
        </xref>
      </contrib>
      <contrib id="jcmm15618-cr-0002" contrib-type="author">
        <name>
          <surname>Wu</surname>
          <given-names>Yanling</given-names>
        </name>
        <xref ref-type="aff" rid="jcmm15618-aff-0001">
          <sup>1</sup>
        </xref>
        <xref ref-type="aff" rid="jcmm15618-aff-0002">
          <sup>2</sup>
        </xref>
      </contrib>
      <contrib id="jcmm15618-cr-0003" contrib-type="author">
        <name>
          <surname>Wang</surname>
          <given-names>Xiaowei</given-names>
        </name>
        <xref ref-type="aff" rid="jcmm15618-aff-0001">
          <sup>1</sup>
        </xref>
        <xref ref-type="aff" rid="jcmm15618-aff-0002">
          <sup>2</sup>
        </xref>
      </contrib>
      <contrib id="jcmm15618-cr-0004" contrib-type="author">
        <name>
          <surname>Li</surname>
          <given-names>Shuwei</given-names>
        </name>
        <xref ref-type="aff" rid="jcmm15618-aff-0001">
          <sup>1</sup>
        </xref>
        <xref ref-type="aff" rid="jcmm15618-aff-0002">
          <sup>2</sup>
        </xref>
      </contrib>
      <contrib id="jcmm15618-cr-0005" contrib-type="author">
        <name>
          <surname>Chu</surname>
          <given-names>Haiyan</given-names>
        </name>
        <xref ref-type="aff" rid="jcmm15618-aff-0001">
          <sup>1</sup>
        </xref>
        <xref ref-type="aff" rid="jcmm15618-aff-0002">
          <sup>2</sup>
        </xref>
      </contrib>
      <contrib id="jcmm15618-cr-0006" contrib-type="author">
        <name>
          <surname>Wang</surname>
          <given-names>Meilin</given-names>
        </name>
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-4996-958X</contrib-id>
        <xref ref-type="aff" rid="jcmm15618-aff-0001">
          <sup>1</sup>
        </xref>
        <xref ref-type="aff" rid="jcmm15618-aff-0002">
          <sup>2</sup>
        </xref>
      </contrib>
      <contrib id="jcmm15618-cr-0007" contrib-type="author" corresp="yes">
        <name>
          <surname>Du</surname>
          <given-names>Mulong</given-names>
        </name>
        <xref ref-type="aff" rid="jcmm15618-aff-0003">
          <sup>3</sup>
        </xref>
        <address>
          <email>drdumulong@njmu.edu.cn</email>
        </address>
      </contrib>
      <contrib id="jcmm15618-cr-0008" contrib-type="author" corresp="yes">
        <name>
          <surname>Zhang</surname>
          <given-names>Zhengdong</given-names>
        </name>
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-6730-9251</contrib-id>
        <xref ref-type="aff" rid="jcmm15618-aff-0001">
          <sup>1</sup>
        </xref>
        <xref ref-type="aff" rid="jcmm15618-aff-0002">
          <sup>2</sup>
        </xref>
        <address>
          <email>drzdzhang@njmu.edu.cn</email>
        </address>
      </contrib>
    </contrib-group>
    <aff id="jcmm15618-aff-0001">
      <label>
        <sup>1</sup>
      </label>
      <named-content content-type="organisation-division">Department of Environmental Genomics</named-content>
      <named-content content-type="organisation-division">Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment</named-content>
      <named-content content-type="organisation-division">Collaborative Innovation Center for Cancer Personalized Medicine</named-content>
      <named-content content-type="organisation-division">School of Public Health</named-content>
      <institution>Nanjing Medical University</institution>
      <city>Nanjing</city>
      <country country="CN">China</country>
    </aff>
    <aff id="jcmm15618-aff-0002">
      <label>
        <sup>2</sup>
      </label>
      <named-content content-type="organisation-division">Department of Genetic Toxicology</named-content>
      <named-content content-type="organisation-division">The Key Laboratory of Modern Toxicology of Ministry of Education</named-content>
      <named-content content-type="organisation-division">Center for Global Health</named-content>
      <named-content content-type="organisation-division">School of Public Health</named-content>
      <institution>Nanjing Medical University</institution>
      <city>Nanjing</city>
      <country country="CN">China</country>
    </aff>
    <aff id="jcmm15618-aff-0003">
      <label>
        <sup>3</sup>
      </label>
      <named-content content-type="organisation-division">Department of Biostatistics</named-content>
      <named-content content-type="organisation-division">Center for Global Health</named-content>
      <named-content content-type="organisation-division">School of Public Health</named-content>
      <institution>Nanjing Medical University</institution>
      <city>Nanjing</city>
      <country country="CN">China</country>
    </aff>
    <author-notes>
      <corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>
Zhengdong Zhang, Department of Environmental Genomics, School of Public Health, Nanjing Medical University, 101 Longmian Avenue Jiangning District, Nanjing 211166, China.<break/>
Email: <email>drzdzhang@njmu.edu.cn</email><break/>
Mulong Du, Department of Biostatistics, School of Public Health, Nanjing Medical University, 101 Longmian Avenue Jiangning District, Nanjing 211166, China.<break/>
Email: <email>drdumulong@njmu.edu.cn</email><break/></corresp>
    </author-notes>
    <pub-date pub-type="epub">
      <day>10</day>
      <month>7</month>
      <year>2020</year>
    </pub-date>
    <pub-date pub-type="ppub">
      <month>8</month>
      <year>2020</year>
    </pub-date>
    <volume>24</volume>
    <issue>16</issue>
    <issue-id pub-id-type="doi">10.1111/jcmm.v24.16</issue-id>
    <fpage>9457</fpage>
    <lpage>9465</lpage>
    <history>
      <date date-type="received">
        <day>26</day>
        <month>9</month>
        <year>2019</year>
      </date>
      <date date-type="rev-recd">
        <day>15</day>
        <month>6</month>
        <year>2020</year>
      </date>
      <date date-type="accepted">
        <day>23</day>
        <month>6</month>
        <year>2020</year>
      </date>
    </history>
    <permissions>
      <!--<copyright-statement content-type="issue-copyright"> Copyright &#x000a9; 2020 Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine <copyright-statement>-->
      <copyright-statement content-type="article-copyright">© 2020 The Authors. <italic>Journal of Cellular and Molecular Medicine</italic> published by Foundation for Cellular and Molecular Medicine and John Wiley &amp; Sons Ltd</copyright-statement>
      <license license-type="creativeCommonsBy">
        <license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <self-uri content-type="pdf" xlink:href="file:JCMM-24-9457.pdf"/>
    <abstract id="jcmm15618-abs-0001">
      <title>Abstract</title>
      <p>Gastric cancer (GC) is a heterogeneous tumour with numerous differences of epidemiologic and clinicopathologic features between cardia cancer and non‐cardia cancer. However, few studies were performed to construct site‐specific GC prognostic models. In this study, we identified site‐specific GC transcriptomic prognostic biomarkers using genetic algorithm (GA)‐based support vector machine (GA‐SVM) and GA‐based Cox regression method (GA‐Cox) in the Cancer Genome Atlas (TCGA) database. The area under time‐dependent receive operating characteristic (ROC) curve (AUC) regarding 5‐year survival and concordance index (C‐index) was used to evaluate the predictive ability of Cox regression models. Finally, we identified 10 and 13 prognostic biomarkers for cardia cancer and non‐cardia cancer, respectively. Compared to traditional models, the addition of these site‐specific biomarkers could notably improve the model preference (cardia: AUC<sub>traditional</sub> vs AUC<sub>combined</sub> = 0.720 vs 0.899, <italic>P</italic> = 8.75E‐08; non‐cardia: AUC<sub>traditional</sub> vs AUC<sub>combined</sub> = 0.798 vs 0.994, <italic>P</italic> = 7.11E‐16). The combined nomograms exhibited superior performance in cardia and non‐cardia GC survival prediction (C‐index<sub>cardia</sub> = 0.816; C‐index<sub>noncardia</sub> = 0.812). We also constructed a user‐friendly GC site‐specific molecular system (GC‐SMS, <ext-link ext-link-type="uri" xlink:href="https://njmu-zhanglab.shinyapps.io/gc_sms/">https://njmu‐zhanglab.shinyapps.io/gc_sms/</ext-link>), which is freely available for users. In conclusion, we developed site‐specific GC prognostic models for predicting cardia cancer and non‐cardia cancer survival, providing more support for the individualized therapy of GC patients.</p>
    </abstract>
    <kwd-group>
      <kwd id="jcmm15618-kwd-0001">biomarker</kwd>
      <kwd id="jcmm15618-kwd-0002">gastric cancer</kwd>
      <kwd id="jcmm15618-kwd-0003">genetic algorithm</kwd>
      <kwd id="jcmm15618-kwd-0004">prognosis</kwd>
      <kwd id="jcmm15618-kwd-0005">site specificity</kwd>
    </kwd-group>
    <funding-group>
      <award-group id="funding-0001">
        <funding-source>National Key R&amp;D Program of China</funding-source>
        <award-id>2018YFC1313100</award-id>
        <award-id>2018YFC1313102</award-id>
      </award-group>
    </funding-group>
    <counts>
      <fig-count count="3"/>
      <table-count count="2"/>
      <page-count count="9"/>
      <word-count count="5059"/>
    </counts>
    <custom-meta-group>
      <custom-meta>
        <meta-name>source-schema-version-number</meta-name>
        <meta-value>2.0</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>cover-date</meta-name>
        <meta-value>August 2020</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>details-of-publishers-convertor</meta-name>
        <meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:5.8.6 mode:remove_FC converted:11.08.2020</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
  <notes>
    <p content-type="self-citation">
      <mixed-citation publication-type="journal" id="jcmm15618-cit-1001"><string-name><surname>Xin</surname><given-names>J</given-names></string-name>, <string-name><surname>Wu</surname><given-names>Y</given-names></string-name>, <string-name><surname>Wang</surname><given-names>X</given-names></string-name>, et al. <article-title>A transcriptomic study for identifying cardia‐ and non–cardia‐specific gastric cancer prognostic factors using genetic algorithm‐based methods</article-title>. <source xml:lang="en">J Cell Mol Med</source>. <year>2020</year>;<volume>24</volume>:<fpage>9457</fpage>–<lpage>9465</lpage>. <pub-id pub-id-type="doi">10.1111/jcmm.15618</pub-id></mixed-citation>
    </p>
    <fn-group id="jcmm15618-ntgp-0001">
      <fn id="jcmm15618-note-0001">
        <p>Junyi Xin, Yanling Wu and Xiaowei Wang contributed equally to this work.</p>
      </fn>
      <fn fn-type="funding" id="jcmm15618-note-0002">
        <p>
          <bold>Funding information</bold>
        </p>
        <p>This study was supported in part by the National Key R&amp;D Program of China (grants 2018YFC1313100, 2018YFC1313102).</p>
      </fn>
    </fn-group>
  </notes>
</front>
<body id="jcmm15618-body-0001">
  <sec id="jcmm15618-sec-0001">
    <label>1</label>
    <title>INTRODUCTION</title>
    <p>Gastric cancer (GC) is the fifth most common cancer and the third leading cause of cancer death worldwide, with estimated 1.03 million new cases and 0.78 million deaths in 2018.<xref rid="jcmm15618-bib-0001" ref-type="ref"><sup>1</sup></xref> Based on pathogenic site, GC can be classified into cardia cancer and non‐cardia cancer. To date, amounting studies have demonstrated that GC is a heterogeneous tumour with numerous differences of epidemiologic and clinicopathologic features between cardia cancer and non‐cardia cancer.<xref rid="jcmm15618-bib-0002" ref-type="ref"><sup>2</sup></xref>, <xref rid="jcmm15618-bib-0003" ref-type="ref"><sup>3</sup></xref>
</p>
    <p>It is well known that GC patients have a poor prognosis with a 5‐year overall survival rate &lt;40%.<xref rid="jcmm15618-bib-0004" ref-type="ref"><sup>4</sup></xref> Meanwhile, several studies have found that the survival rate of cardia cancer patients was significantly lower than that of non‐cardia cancer patients, indicating the diverse prognosis between cardia cancer and non‐cardia cancer.<xref rid="jcmm15618-bib-0005" ref-type="ref"><sup>5</sup></xref>, <xref rid="jcmm15618-bib-0006" ref-type="ref"><sup>6</sup></xref> Besides, growing evidence has revealed that, in addition to clinical factors (eg age and clinical stage), genetic factors (eg genetic variants and genes expression level) may play important roles in GC survival prediction.<xref rid="jcmm15618-bib-0007" ref-type="ref"><sup>7</sup></xref>, <xref rid="jcmm15618-bib-0008" ref-type="ref"><sup>8</sup></xref> Therefore, it is required to find potential site‐specific biomarkers that can be used to individually predict cardia and non‐cardia GC prognosis.</p>
    <p>Recently, with the development of high‐throughput biotechnology, how to perform feature selection in high‐dimensional data with relatively small sample size has been a great challenge. Genetic algorithm (GA), a searching algorithm based on natural selection, crossover and mutation, has been reported to be a very efficient method for feature selection.<xref rid="jcmm15618-bib-0009" ref-type="ref"><sup>9</sup></xref> Several studies have demonstrated that GA‐based features selection methods can significantly improve the predictive accuracy of diseases risk prediction models.<xref rid="jcmm15618-bib-0010" ref-type="ref"><sup>10</sup></xref>, <xref rid="jcmm15618-bib-0011" ref-type="ref"><sup>11</sup></xref>
</p>
    <p>In this study, to identify potential cardia‐ and non–cardia‐specific GC prognostic biomarkers, we performed a comprehensive analysis using GA‐based support vector machine (GA‐SVM) and GA‐based Cox regression method (GA‐Cox) in the Cancer Genome Atlas (TCGA) stomach adenocarcinoma (STAD) transcriptomic data.</p>
  </sec>
  <sec sec-type="materials-and-methods" id="jcmm15618-sec-0002">
    <label>2</label>
    <title>MATERIALS AND METHODS</title>
    <sec id="jcmm15618-sec-0003">
      <label>2.1</label>
      <title>Data collection</title>
      <p>We downloaded GC transcriptomic RNA sequence data with clear definitions of tumour origin from TCGA STAD database (October 30, 2018), including gene expression data sets (fragments per kilobase of transcript per million mapped reads [FPKM], 359 GC tumour tissues and 32 normal tissues), lncRNA expression datasets (FPKM, 359 GC tumour tissues and 32 normal tissues) and miRNA expression data sets (reads per million [RPM], 417 GC tumour tissues and 41 normal tissues) for analysis. Furthermore, a total of 87 cardia and 264 non‐cardia cancer patients with complete transcriptomic data and follow‐up information were remained for comprehensive survival analysis.</p>
    </sec>
    <sec id="jcmm15618-sec-0004">
      <label>2.2</label>
      <title>Site‐specific biomarkers identification</title>
      <p>The TCGA STAD data were firstly normalized by log<sub>2</sub> (<italic>x</italic> + 1) transformed. We separately used unpaired Student's <italic>t</italic> test to perform differential expression analysis in cardia and non‐cardia cancers, and extracted site‐specific biomarkers based on the following criteria: (a) call rate (percent of biomarkers with expression value &gt;0) &gt;70%; (b) |log<sub>2</sub>(fold change [FC])| &gt; 1; (c) <italic>P</italic> value for Student's <italic>t</italic> test &lt; 0.05; and (d) <italic>P</italic> value for univariate Cox test &lt; 0.05.</p>
    </sec>
    <sec id="jcmm15618-sec-0005">
      <label>2.3</label>
      <title>GA‐SVM</title>
      <p>To obtain the transcriptomic biomarkers with highest discriminatory power in distinguishing cardia and non‐cardia tumour tissues, we performed GA‐SVM analysis in genes, miRNAs and lncRNAs data sets, respectively (Figure <xref rid="jcmm15618-fig-0001" ref-type="fig">1</xref>). The procedures of GA‐SVM are divided into three steps: (a) GA analysis: perform the GA procedure including selection, crossover and mutation for 200 generations, the fitness is measured using the threefold cross‐validated area under receive operating characteristic (ROC) curve (AUC); (b) variables sort: extract the top 50 variable sets with the highest AUC and calculate each variable's frequency, variables are then sorted by their frequencies in decreasing order; (c) variables selection: construct SVM model with the addition of order‐sorted variables, and obtain a set of variables with the highest threefold cross‐validated AUC (Figure <xref rid="jcmm15618-sup-0001" ref-type="supplementary-material">S1</xref>).</p>
      <fig fig-type="FIGURE" xml:lang="en" id="jcmm15618-fig-0001" orientation="portrait" position="float">
        <label>FIGURE 1</label>
        <caption>
          <p>Summary of this study design</p>
        </caption>
        <graphic id="nlm-graphic-1" xlink:href="JCMM-24-9457-g001"/>
      </fig>
    </sec>
    <sec id="jcmm15618-sec-0006">
      <label>2.4</label>
      <title>GA‐Cox and site‐specific risk scores construction</title>
      <p>Furthermore, we applied GA‐Cox analysis to identify prognostic factors with highest predictive power in evaluating cardia and non‐cardia GC patients' survival, respectively (Figure <xref rid="jcmm15618-fig-0001" ref-type="fig">1</xref>). Similar to GA‐SVM, the procedures of GA‐Cox are described as follows: (a) GA analysis: perform the GA procedure for 200 generations, the threefold cross‐validated AUC of time‐dependent ROC curve regarding 5‐year survival is used to evaluate the fitness; (b) variables sort: variables identified in the optimal 50 variable sets are sorted by their frequencies in decreasing order; (c) risk score calculation: calculate risk score with the addition of order‐sorted variables, the risk score is defined as: <mml:math id="nlm-math-1"><mml:mrow><mml:munderover><mml:mo movablelimits="false">∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>n</mml:mi></mml:munderover><mml:msub><mml:mi>β</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:msub><mml:mi>X</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:math>, where <italic>n</italic> is the number of biomarkers, <italic>β<sub>i</sub></italic> is the Cox regression coefficient for biomarker <italic>i</italic>, and <italic>X<sub>i</sub></italic> is the expression level (log<sub>2</sub> transformed) of biomarker <italic>i</italic>; (d) variables selection: construct Cox model using risk score calculated by adding each variable score, and identify a set of site‐specific prognostic factors with the highest threefold cross‐validated AUC (Figure <xref rid="jcmm15618-sup-0001" ref-type="supplementary-material">S1</xref>).</p>
      <p>To evaluate the clinical utility of the site‐specific risk scores calculated by transcriptomic biomarkers in predicting GC survival probability, we used the median of risk score to divide the patients into a high‐ and low‐risk groups among cardia and non‐cardia GC patients. The Kaplan–Meier survival curve and log‐rank test were then applied to compare the survival probability between two groups.</p>
    </sec>
    <sec id="jcmm15618-sec-0007">
      <label>2.5</label>
      <title>Site‐specific clinical prognostic models construction</title>
      <p>We used Cox regression model to perform univariate analysis and multivariate analysis for identifying clinical prognostic factors. After univariate analysis, Cox stepwise regression analysis was used to further screen independent clinical characteristics, with a significance level of <italic>P</italic> &lt; 0.05 for entering and <italic>P</italic> &gt; 0.10 for removing variables. The remaining clinical prognostic factors were used to construct traditional cardia and non‐cardia GC prognostic models.</p>
    </sec>
    <sec id="jcmm15618-sec-0008">
      <label>2.6</label>
      <title>Site‐specific combined prognostic models construction</title>
      <p>We further used site‐specific clinical factors and risk scores to construct combined cardia and non‐cardia GC prognostic model. The predictive power of prognostic model was measured using time‐dependent ROC curve regarding 5‐year survival with R package survivalROC. Besides, the threefold cross‐validation test was used to avoid potential over‐fitting. The difference of ROC curves was evaluated using Wilcoxon rank‐sum test with R package survcomp.</p>
    </sec>
    <sec id="jcmm15618-sec-0009">
      <label>2.7</label>
      <title>Site‐specific GC nomograms construction</title>
      <p>To predict the overall survival probability of cardia and non‐cardia GC patients, the regression coefficients in multivariable Cox regression model were used to generate the nomogram using R package rms, each patient could obtain the total points from the nomogram. The concordance index (C‐index) was then estimated to evaluate the similarity between the actual and predicted survival probability, the larger C‐index (ranges from 0 to 1) indicates a better model performance. The C‐index was also adjusted by bootstrap method with 1000 resamples. Besides, the calibration plot and decision curve were used to evaluate the calibration and clinical utility of the nomograms.</p>
    </sec>
    <sec id="jcmm15618-sec-0010">
      <label>2.8</label>
      <title>Construction of a user‐friendly webserver</title>
      <p>We used R package Shiny (R Core Team, Vienna, Austria) to construct a GC site‐specific molecular system (GC‐SMS), which is freely available and user‐friendly. This system included site‐specific GC molecular databases and survival prediction models. The molecular databases provided the results of differential expression analysis and survival analysis for each biomarker at different GC sites. The survival prediction models could provide the predicted 5‐year survival probability for cardia and non‐cardia GC patients. Total points and corresponding survival probability were calculated by R package nomogramEx (R Core Team, Vienna, Austria).</p>
      <p>All analyses were performed using R 3.4.1 software (R Core Team, Vienna, Austria). <italic>P</italic> &lt; 0.05 (two‐side) was statistically significant.</p>
    </sec>
  </sec>
  <sec sec-type="results" id="jcmm15618-sec-0011">
    <label>3</label>
    <title>RESULTS</title>
    <sec id="jcmm15618-sec-0012">
      <label>3.1</label>
      <title>Basic characteristics of study subjects</title>
      <p>The detailed clinical characteristics of 87 cardia and 264 non‐cardia cancer patients are summarized in Table <xref rid="jcmm15618-sup-0001" ref-type="supplementary-material">S1</xref>. There was a significant difference in neoplasm status (<italic>P</italic> = 0.002) between cardia (28 cases with tumour, 36.36%) and non‐cardia (44 cases with tumour, 19.21%) cancer patients, but the difference of other clinical characteristics (eg sex and age) was not significant (<italic>P</italic> &gt; 0.05).</p>
    </sec>
    <sec id="jcmm15618-sec-0013">
      <label>3.2</label>
      <title>Identification of prognostic biomarkers</title>
      <p>We first used a series of filtering criteria to obtain cardia (including 127 genes, 3 miRNAs and 86 lncRNAs) and non‐cardia (including 368 genes, 13 miRNAs and 136 lncRNAs) specific prognostic biomarkers (Figure <xref rid="jcmm15618-fig-0001" ref-type="fig">1</xref>). GA‐SVM analysis was subsequently used to identify key biomarkers with highest discriminatory power in distinguishing cardia and non‐cardia tumour tissues. Finally, 116 genes (AUC = 0.822; cardia: 26; non‐cardia: 90), 10 miRNAs (AUC = 0.714; cardia: 2; non‐cardia: 8) and 26 lncRNAs (AUC = 0.816; cardia: 11; non‐cardia: 15) were screened for further survival analysis (Figure <xref rid="jcmm15618-sup-0001" ref-type="supplementary-material">S2</xref>).</p>
      <p>Moreover, we applied GA‐Cox analysis to identify key transcriptomic prognostic factors for predicting cardia and non‐cardia GC survival using 39 cardia‐ and 113 non–cardia‐specific biomarkers (Figure <xref rid="jcmm15618-fig-0001" ref-type="fig">1</xref>). For cardia cancer patients, a total of 10 prognostic biomarkers including 7 genes (Table <xref rid="jcmm15618-sup-0001" ref-type="supplementary-material">S2</xref>) and 3 lncRNAs, with an AUC of 0.913 (Figure <xref rid="jcmm15618-sup-0001" ref-type="supplementary-material">S3</xref>), were finally identified (Table <xref rid="jcmm15618-tbl-0001" ref-type="table">1</xref>). For non‐cardia cancer patients, we identified 13 prognostic biomarkers including 10 genes (Table <xref rid="jcmm15618-sup-0001" ref-type="supplementary-material">S2</xref>), 2 miRNAs and 1 lncRNA (AUC = 0.918, Figure <xref rid="jcmm15618-sup-0001" ref-type="supplementary-material">S3</xref>; Table <xref rid="jcmm15618-tbl-0002" ref-type="table">2</xref>). Furthermore, we divided the patients into high‐ and low‐risk groups using the median of risk score constructed by these biomarkers (Figure <xref rid="jcmm15618-fig-0002" ref-type="fig">2A,B</xref>). Broadly, compared to low‐risk group, high‐risk group had poorer prognosis among cardia and non‐cardia GC patients (log‐rank <italic>P</italic> &lt; 0.001, Figure <xref rid="jcmm15618-fig-0002" ref-type="fig">2C,D</xref>).</p>
      <table-wrap id="jcmm15618-tbl-0001" xml:lang="en" content-type="TABLE" orientation="portrait" position="float">
        <label>TABLE 1</label>
        <caption>
          <p>Summary of 10 cardia‐specific gastric cancer (GC) prognostic biomarkers</p>
        </caption>
        <table frame="hsides" rules="groups">
          <col style="border-right:solid 1px #000000" span="1"/>
          <col style="border-right:solid 1px #000000" span="1"/>
          <col style="border-right:solid 1px #000000" span="1"/>
          <col style="border-right:solid 1px #000000" span="1"/>
          <col style="border-right:solid 1px #000000" span="1"/>
          <col style="border-right:solid 1px #000000" span="1"/>
          <col style="border-right:solid 1px #000000" span="1"/>
          <col style="border-right:solid 1px #000000" span="1"/>
          <col style="border-right:solid 1px #000000" span="1"/>
          <thead valign="top">
            <tr style="border-bottom:solid 1px #000000">
              <th align="left" valign="top" rowspan="1" colspan="1">Biomarkers</th>
              <th align="left" valign="top" rowspan="1" colspan="1">Prognostic factors</th>
              <th align="left" valign="top" rowspan="1" colspan="1">Ensembl ID</th>
              <th align="left" valign="top" rowspan="1" colspan="1">Tumour<xref ref-type="fn" rid="jcmm15618-note-0003"><sup>a</sup></xref>
</th>
              <th align="left" valign="top" rowspan="1" colspan="1">Normal<xref ref-type="fn" rid="jcmm15618-note-0003"><sup>a</sup></xref>
</th>
              <th align="left" valign="top" rowspan="1" colspan="1">FC<xref ref-type="fn" rid="jcmm15618-note-0004"><sup>b</sup></xref>
</th>
              <th align="left" valign="top" rowspan="1" colspan="1">
                <italic>P</italic>
                <xref ref-type="fn" rid="jcmm15618-note-0005">
                  <sup>c</sup>
                </xref>
              </th>
              <th align="left" valign="top" rowspan="1" colspan="1">HR (95% CI)<xref ref-type="fn" rid="jcmm15618-note-0006"><sup>d</sup></xref>
</th>
              <th align="left" valign="top" rowspan="1" colspan="1">
                <italic>P</italic>
                <xref ref-type="fn" rid="jcmm15618-note-0006">
                  <sup>d</sup>
                </xref>
              </th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" rowspan="7" colspan="1">Gene</td>
              <td align="left" rowspan="1" colspan="1">
                <italic>TUBB1</italic>
              </td>
              <td align="left" rowspan="1" colspan="1">ENSG00000101162.3</td>
              <td align="char" char="." rowspan="1" colspan="1">0.18</td>
              <td align="char" char="." rowspan="1" colspan="1">0.07</td>
              <td align="char" char="." rowspan="1" colspan="1">2.42</td>
              <td align="left" rowspan="1" colspan="1">4.16E‐04</td>
              <td align="left" rowspan="1" colspan="1">5.00 (1.32, 18.99)</td>
              <td align="left" rowspan="1" colspan="1">1.80E‐02</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">
                <italic>APAF1</italic>
              </td>
              <td align="left" rowspan="1" colspan="1">ENSG00000120868.12</td>
              <td align="char" char="." rowspan="1" colspan="1">3.68</td>
              <td align="char" char="." rowspan="1" colspan="1">1.80</td>
              <td align="char" char="." rowspan="1" colspan="1">2.04</td>
              <td align="left" rowspan="1" colspan="1">5.62E‐05</td>
              <td align="left" rowspan="1" colspan="1">0.50 (0.26, 0.96)</td>
              <td align="left" rowspan="1" colspan="1">3.72E‐02</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">
                <italic>FAM131B</italic>
              </td>
              <td align="left" rowspan="1" colspan="1">ENSG00000159784.16</td>
              <td align="char" char="." rowspan="1" colspan="1">0.54</td>
              <td align="char" char="." rowspan="1" colspan="1">0.18</td>
              <td align="char" char="." rowspan="1" colspan="1">2.99</td>
              <td align="left" rowspan="1" colspan="1">8.78E‐03</td>
              <td align="left" rowspan="1" colspan="1">0.19 (0.04, 0.91)</td>
              <td align="left" rowspan="1" colspan="1">3.72E‐02</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">
                <italic>EN1</italic>
              </td>
              <td align="left" rowspan="1" colspan="1">ENSG00000163064.6</td>
              <td align="char" char="." rowspan="1" colspan="1">0.11</td>
              <td align="char" char="." rowspan="1" colspan="1">0.02</td>
              <td align="char" char="." rowspan="1" colspan="1">7.07</td>
              <td align="left" rowspan="1" colspan="1">2.35E‐04</td>
              <td align="left" rowspan="1" colspan="1">3.19 (1.37, 7.40)</td>
              <td align="left" rowspan="1" colspan="1">6.92E‐03</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">
                <italic>TMEM200A</italic>
              </td>
              <td align="left" rowspan="1" colspan="1">ENSG00000164484.10</td>
              <td align="char" char="." rowspan="1" colspan="1">2.14</td>
              <td align="char" char="." rowspan="1" colspan="1">0.54</td>
              <td align="char" char="." rowspan="1" colspan="1">4.00</td>
              <td align="left" rowspan="1" colspan="1">1.34E‐04</td>
              <td align="left" rowspan="1" colspan="1">1.38 (1.00, 1.90)</td>
              <td align="left" rowspan="1" colspan="1">4.70E‐02</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">
                <italic>SYT12</italic>
              </td>
              <td align="left" rowspan="1" colspan="1">ENSG00000173227.12</td>
              <td align="char" char="." rowspan="1" colspan="1">0.57</td>
              <td align="char" char="." rowspan="1" colspan="1">0.15</td>
              <td align="char" char="." rowspan="1" colspan="1">3.86</td>
              <td align="left" rowspan="1" colspan="1">4.81E‐03</td>
              <td align="left" rowspan="1" colspan="1">1.71 (1.05, 2.78)</td>
              <td align="left" rowspan="1" colspan="1">3.13E‐02</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">
                <italic>WFDC10B</italic>
              </td>
              <td align="left" rowspan="1" colspan="1">ENSG00000182931.8</td>
              <td align="char" char="." rowspan="1" colspan="1">0.39</td>
              <td align="char" char="." rowspan="1" colspan="1">0.03</td>
              <td align="char" char="." rowspan="1" colspan="1">11.94</td>
              <td align="left" rowspan="1" colspan="1">3.86E‐06</td>
              <td align="left" rowspan="1" colspan="1">2.51 (1.48, 4.25)</td>
              <td align="left" rowspan="1" colspan="1">6.50E‐04</td>
            </tr>
            <tr>
              <td align="left" rowspan="3" colspan="1">lncRNA</td>
              <td align="left" rowspan="1" colspan="1">AC016575.1</td>
              <td align="left" rowspan="1" colspan="1">ENSG00000272057.1</td>
              <td align="char" char="." rowspan="1" colspan="1">0.16</td>
              <td align="char" char="." rowspan="1" colspan="1">0.07</td>
              <td align="char" char="." rowspan="1" colspan="1">2.26</td>
              <td align="left" rowspan="1" colspan="1">1.86E‐02</td>
              <td align="left" rowspan="1" colspan="1">5.47 (1.19, 25.07)</td>
              <td align="left" rowspan="1" colspan="1">2.87E‐02</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">LINC02728</td>
              <td align="left" rowspan="1" colspan="1">ENSG00000251323.2</td>
              <td align="char" char="." rowspan="1" colspan="1">0.20</td>
              <td align="char" char="." rowspan="1" colspan="1">0.07</td>
              <td align="char" char="." rowspan="1" colspan="1">3.04</td>
              <td align="left" rowspan="1" colspan="1">6.78E‐03</td>
              <td align="left" rowspan="1" colspan="1">3.85 (1.57, 9.43)</td>
              <td align="left" rowspan="1" colspan="1">3.22E‐03</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">LINC00412</td>
              <td align="left" rowspan="1" colspan="1">ENSG00000234772.1</td>
              <td align="char" char="." rowspan="1" colspan="1">0.16</td>
              <td align="char" char="." rowspan="1" colspan="1">0.04</td>
              <td align="char" char="." rowspan="1" colspan="1">4.11</td>
              <td align="left" rowspan="1" colspan="1">1.76E‐04</td>
              <td align="left" rowspan="1" colspan="1">0.11 (0.01, 0.93)</td>
              <td align="left" rowspan="1" colspan="1">4.28E‐02</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot id="jcmm15618-ntgp-0002">
          <fn id="jcmm15618-note-0003">
            <label>
              <sup>a</sup>
            </label>
            <p>Mean value in cardia tissues.</p>
          </fn>
          <fn id="jcmm15618-note-0004">
            <label>
              <sup>b</sup>
            </label>
            <p>Fold change, Tumour/Normal.</p>
          </fn>
          <fn id="jcmm15618-note-0005">
            <label>
              <sup>c</sup>
            </label>
            <p><italic>P</italic> value for Student's <italic>t</italic> test in cardia tissues.</p>
          </fn>
          <fn id="jcmm15618-note-0006">
            <label>
              <sup>d</sup>
            </label>
            <p>Univariate Cox regression in cardia tissues.</p>
          </fn>
        </table-wrap-foot>
        <permissions>
          <copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
        </permissions>
      </table-wrap>
      <table-wrap id="jcmm15618-tbl-0002" xml:lang="en" content-type="TABLE" orientation="portrait" position="float">
        <label>TABLE 2</label>
        <caption>
          <p>Summary of 13 non–cardia‐specific gastric cancer (GC) prognostic biomarkers</p>
        </caption>
        <table frame="hsides" rules="groups">
          <col style="border-right:solid 1px #000000" span="1"/>
          <col style="border-right:solid 1px #000000" span="1"/>
          <col style="border-right:solid 1px #000000" span="1"/>
          <col style="border-right:solid 1px #000000" span="1"/>
          <col style="border-right:solid 1px #000000" span="1"/>
          <col style="border-right:solid 1px #000000" span="1"/>
          <col style="border-right:solid 1px #000000" span="1"/>
          <col style="border-right:solid 1px #000000" span="1"/>
          <col style="border-right:solid 1px #000000" span="1"/>
          <thead valign="top">
            <tr style="border-bottom:solid 1px #000000">
              <th align="left" valign="top" rowspan="1" colspan="1">Biomarkers</th>
              <th align="left" valign="top" rowspan="1" colspan="1">Prognostic factors</th>
              <th align="left" valign="top" rowspan="1" colspan="1">Ensembl ID</th>
              <th align="left" valign="top" rowspan="1" colspan="1">Tumour<xref ref-type="fn" rid="jcmm15618-note-0007"><sup>a</sup></xref>
</th>
              <th align="left" valign="top" rowspan="1" colspan="1">Normal<xref ref-type="fn" rid="jcmm15618-note-0007"><sup>a</sup></xref>
</th>
              <th align="left" valign="top" rowspan="1" colspan="1">FC<xref ref-type="fn" rid="jcmm15618-note-0008"><sup>b</sup></xref>
</th>
              <th align="left" valign="top" rowspan="1" colspan="1">
                <italic>P</italic>
                <xref ref-type="fn" rid="jcmm15618-note-0009">
                  <sup>c</sup>
                </xref>
              </th>
              <th align="left" valign="top" rowspan="1" colspan="1">HR (95% CI)<xref ref-type="fn" rid="jcmm15618-note-0010"><sup>d</sup></xref>
</th>
              <th align="left" valign="top" rowspan="1" colspan="1">
                <italic>P</italic>
                <xref ref-type="fn" rid="jcmm15618-note-0010">
                  <sup>d</sup>
                </xref>
              </th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" rowspan="10" colspan="1">Gene</td>
              <td align="left" rowspan="1" colspan="1">
                <italic>CREB3L3</italic>
              </td>
              <td align="left" rowspan="1" colspan="1">ENSG00000060566.12</td>
              <td align="char" char="." rowspan="1" colspan="1">4.67</td>
              <td align="char" char="." rowspan="1" colspan="1">54.76</td>
              <td align="char" char="." rowspan="1" colspan="1">0.09</td>
              <td align="left" rowspan="1" colspan="1">2.06E‐02</td>
              <td align="left" rowspan="1" colspan="1">1.16 (1.03, 1.31)</td>
              <td align="left" rowspan="1" colspan="1">1.74E‐02</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">
                <italic>CHADL</italic>
              </td>
              <td align="left" rowspan="1" colspan="1">ENSG00000100399.14</td>
              <td align="char" char="." rowspan="1" colspan="1">1.00</td>
              <td align="char" char="." rowspan="1" colspan="1">2.13</td>
              <td align="char" char="." rowspan="1" colspan="1">0.47</td>
              <td align="left" rowspan="1" colspan="1">3.20E‐07</td>
              <td align="left" rowspan="1" colspan="1">0.58 (0.38, 0.87)</td>
              <td align="left" rowspan="1" colspan="1">9.31E‐03</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">
                <italic>LAMP5</italic>
              </td>
              <td align="left" rowspan="1" colspan="1">ENSG00000125869.8</td>
              <td align="char" char="." rowspan="1" colspan="1">2.17</td>
              <td align="char" char="." rowspan="1" colspan="1">0.77</td>
              <td align="char" char="." rowspan="1" colspan="1">2.83</td>
              <td align="left" rowspan="1" colspan="1">2.94E‐04</td>
              <td align="left" rowspan="1" colspan="1">1.27 (1.05, 1.53)</td>
              <td align="left" rowspan="1" colspan="1">1.25E‐02</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">
                <italic>CTSV</italic>
              </td>
              <td align="left" rowspan="1" colspan="1">ENSG00000136943.9</td>
              <td align="char" char="." rowspan="1" colspan="1">3.61</td>
              <td align="char" char="." rowspan="1" colspan="1">0.60</td>
              <td align="char" char="." rowspan="1" colspan="1">5.99</td>
              <td align="left" rowspan="1" colspan="1">9.05E‐12</td>
              <td align="left" rowspan="1" colspan="1">1.22 (1, 1.48)</td>
              <td align="left" rowspan="1" colspan="1">4.89E‐02</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">
                <italic>CYP19A1</italic>
              </td>
              <td align="left" rowspan="1" colspan="1">ENSG00000137869.12</td>
              <td align="char" char="." rowspan="1" colspan="1">0.12</td>
              <td align="char" char="." rowspan="1" colspan="1">0.01</td>
              <td align="char" char="." rowspan="1" colspan="1">11.51</td>
              <td align="left" rowspan="1" colspan="1">5.52E‐19</td>
              <td align="left" rowspan="1" colspan="1">3.10 (1.53, 6.25)</td>
              <td align="left" rowspan="1" colspan="1">1.61E‐03</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">
                <italic>AMDHD1</italic>
              </td>
              <td align="left" rowspan="1" colspan="1">ENSG00000139344.6</td>
              <td align="char" char="." rowspan="1" colspan="1">0.44</td>
              <td align="char" char="." rowspan="1" colspan="1">0.18</td>
              <td align="char" char="." rowspan="1" colspan="1">2.45</td>
              <td align="left" rowspan="1" colspan="1">2.93E‐04</td>
              <td align="left" rowspan="1" colspan="1">0.54 (0.29, 0.98)</td>
              <td align="left" rowspan="1" colspan="1">4.25E‐02</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">
                <italic>ALLC</italic>
              </td>
              <td align="left" rowspan="1" colspan="1">ENSG00000151360.8</td>
              <td align="char" char="." rowspan="1" colspan="1">0.06</td>
              <td align="char" char="." rowspan="1" colspan="1">0.01</td>
              <td align="char" char="." rowspan="1" colspan="1">5.07</td>
              <td align="left" rowspan="1" colspan="1">1.64E‐06</td>
              <td align="left" rowspan="1" colspan="1">3.63 (1.62, 8.12)</td>
              <td align="left" rowspan="1" colspan="1">1.74E‐03</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">
                <italic>NETO2</italic>
              </td>
              <td align="left" rowspan="1" colspan="1">ENSG00000171208.8</td>
              <td align="char" char="." rowspan="1" colspan="1">1.76</td>
              <td align="char" char="." rowspan="1" colspan="1">0.28</td>
              <td align="char" char="." rowspan="1" colspan="1">6.26</td>
              <td align="left" rowspan="1" colspan="1">1.44E‐19</td>
              <td align="left" rowspan="1" colspan="1">1.30 (1.02, 1.64)</td>
              <td align="left" rowspan="1" colspan="1">3.14E‐02</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">
                <italic>HBA2</italic>
              </td>
              <td align="left" rowspan="1" colspan="1">ENSG00000188536.11</td>
              <td align="char" char="." rowspan="1" colspan="1">14.34</td>
              <td align="char" char="." rowspan="1" colspan="1">41.23</td>
              <td align="char" char="." rowspan="1" colspan="1">0.35</td>
              <td align="left" rowspan="1" colspan="1">2.35E‐08</td>
              <td align="left" rowspan="1" colspan="1">1.16 (1.01, 1.32)</td>
              <td align="left" rowspan="1" colspan="1">3.04E‐02</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">
                <italic>C5orf58</italic>
              </td>
              <td align="left" rowspan="1" colspan="1">ENSG00000234511.7</td>
              <td align="char" char="." rowspan="1" colspan="1">0.25</td>
              <td align="char" char="." rowspan="1" colspan="1">0.06</td>
              <td align="char" char="." rowspan="1" colspan="1">4.39</td>
              <td align="left" rowspan="1" colspan="1">2.37E‐14</td>
              <td align="left" rowspan="1" colspan="1">1.91 (1.13, 3.23)</td>
              <td align="left" rowspan="1" colspan="1">1.55E‐02</td>
            </tr>
            <tr>
              <td align="left" rowspan="2" colspan="1">miRNA</td>
              <td align="left" rowspan="1" colspan="1">miR‐7‐2</td>
              <td align="left" rowspan="1" colspan="1">—</td>
              <td align="char" char="." rowspan="1" colspan="1">4.37</td>
              <td align="char" char="." rowspan="1" colspan="1">1.56</td>
              <td align="char" char="." rowspan="1" colspan="1">2.81</td>
              <td align="left" rowspan="1" colspan="1">1.09E‐04</td>
              <td align="left" rowspan="1" colspan="1">0.82 (0.7, 0.98)</td>
              <td align="left" rowspan="1" colspan="1">2.48E‐02</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">miR‐7‐3</td>
              <td align="left" rowspan="1" colspan="1">—</td>
              <td align="char" char="." rowspan="1" colspan="1">4.17</td>
              <td align="char" char="." rowspan="1" colspan="1">1.18</td>
              <td align="char" char="." rowspan="1" colspan="1">3.53</td>
              <td align="left" rowspan="1" colspan="1">2.31E‐06</td>
              <td align="left" rowspan="1" colspan="1">0.83 (0.71, 0.98)</td>
              <td align="left" rowspan="1" colspan="1">3.21E‐02</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">lncRNA</td>
              <td align="left" rowspan="1" colspan="1">LINC01614</td>
              <td align="left" rowspan="1" colspan="1">ENSG00000230838.1</td>
              <td align="char" char="." rowspan="1" colspan="1">1.59</td>
              <td align="char" char="." rowspan="1" colspan="1">0.06</td>
              <td align="char" char="." rowspan="1" colspan="1">28.20</td>
              <td align="left" rowspan="1" colspan="1">3.47E‐37</td>
              <td align="left" rowspan="1" colspan="1">1.36 (1.09, 1.69)</td>
              <td align="left" rowspan="1" colspan="1">6.32E‐03</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot id="jcmm15618-ntgp-0003">
          <fn id="jcmm15618-note-0007">
            <label>
              <sup>a</sup>
            </label>
            <p>Mean value in non‐cardia tissues.</p>
          </fn>
          <fn id="jcmm15618-note-0008">
            <label>
              <sup>b</sup>
            </label>
            <p>Fold change, Tumour/Normal.</p>
          </fn>
          <fn id="jcmm15618-note-0009">
            <label>
              <sup>c</sup>
            </label>
            <p><italic>P</italic> value for Student's <italic>t</italic> test in non‐cardia tissues.</p>
          </fn>
          <fn id="jcmm15618-note-0010">
            <label>
              <sup>d</sup>
            </label>
            <p>Univariate Cox regression in non‐cardia tissues.</p>
          </fn>
        </table-wrap-foot>
        <permissions>
          <copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
        </permissions>
      </table-wrap>
      <fig fig-type="FIGURE" xml:lang="en" id="jcmm15618-fig-0002" orientation="portrait" position="float">
        <label>FIGURE 2</label>
        <caption>
          <p>Risk score analysis for 10 and 13 site‐specific biomarkers in cardia and non‐cardia gastric cancer (GC) patients, respectively. A, B, Distribution of site‐specific risk score and survival status in cardia and non‐cardia GC patients. The black lines represented risk scores. The grey dashed lines represented the median value of risk scores. C, D, Kaplan‐Meier survival curves for overall survival outcomes in cardia and non‐cardia GC patients. E, F, The time‐dependent ROC curves regarding 5‐year for cardia and non‐cardia GC prognostic models</p>
        </caption>
        <graphic id="nlm-graphic-3" xlink:href="JCMM-24-9457-g002"/>
      </fig>
    </sec>
    <sec id="jcmm15618-sec-0014">
      <label>3.3</label>
      <title>Construction of site‐specific traditional and combined prognostic models</title>
      <p>We initially performed univariate analysis to evaluate the association of each clinical factor with cardia and non‐cardia GC survival (Table <xref rid="jcmm15618-sup-0001" ref-type="supplementary-material">S1</xref>). We found two risk factors for cardia cancer prognosis, including neoplasm status (HR = 2.75, <italic>P</italic> = 0.005) and residual tumour (HR = 3.59, <italic>P</italic> = 0.007); and four prognostic factors for non‐cardia cancer, including radiation therapy (HR = 0.45, <italic>P</italic> = 0.021), neoplasm status (HR = 3.90, <italic>P</italic> = 1.94E‐09), residual tumour (HR = 3.31, <italic>P</italic> = 8.30E‐05) and tumour stage (stage 3 vs 1<italic>:</italic> HR = 2.24, <italic>P</italic> = 0.036; stage 4 vs 1: HR = 6.73, <italic>P</italic> = 1.82E‐05). Subsequently, we performed a multivariate Cox stepwise regression analysis to select independent clinical factors for constructing cardia and non‐cardia GC traditional prognostic models (Table <xref rid="jcmm15618-sup-0001" ref-type="supplementary-material">S3</xref>). Finally, neoplasm status (HR = 2.78, <italic>P</italic> = 0.009) was remained in cardia model (AUC = 0.720, Table <xref rid="jcmm15618-sup-0001" ref-type="supplementary-material">S4</xref>). Non‐cardia model (AUC = 0.798, Table <xref rid="jcmm15618-sup-0001" ref-type="supplementary-material">S4</xref>) was constructed using radiation therapy (HR = 0.45, <italic>P</italic> = 0.069), neoplasm status (HR = 3.31, <italic>P</italic> &lt; 0.001) and tumour stage (HR = 1.56, <italic>P</italic> = 0.018).</p>
      <p>We further introduced the risk scores of 10 cardia and 13 non‐cardia cancer prognostic biomarkers to construct combined site‐specific GC prognostic models, respectively. We found that, with the addition of biomarkers, the combined cardia (AUC = 0.899) and non‐cardia (AUC = 0.994) cancer prognostic models showed stronger predictive power (<italic>P</italic>
<sub>cardia</sub> = 8.75E‐08; <italic>P</italic>
<sub>noncardia</sub> = 7.11E‐16, Table <xref rid="jcmm15618-sup-0001" ref-type="supplementary-material">S4</xref>, Figure <xref rid="jcmm15618-fig-0002" ref-type="fig">2E,F</xref>) compared to traditional prognostic models. To avoid the potential over‐fitting, the threefold cross‐validation test was used to further confirm the results (cardia: AUC<sub>traditional</sub> vs AUC<sub>combined</sub> = 0.726 vs 0.867; non‐cardia: AUC<sub>traditional</sub> vs AUC<sub>combined</sub> = 0.797 vs 0.940, Table <xref rid="jcmm15618-sup-0001" ref-type="supplementary-material">S4</xref>).</p>
    </sec>
    <sec id="jcmm15618-sec-0015">
      <label>3.4</label>
      <title>Construction of site‐specific nomograms</title>
      <p>Furthermore, we constructed two nomograms to show the potential clinical application of the two combined models in cardia (Figure <xref rid="jcmm15618-fig-0003" ref-type="fig">3A</xref>) and non‐cardia (Figure <xref rid="jcmm15618-fig-0003" ref-type="fig">3B</xref>) GC patients' prognosis prediction. Based on the nomograms including multiple prognostic factors, we could predict the 5‐year overall survival probability of cardia and non‐cardia GC patients by drawing a vertical line to the total points. The C‐index for cardia and non‐cardia GC models was 0.816 (95% CI = 0.710‐0.923, adjusted C‐index = 0.811) and 0.812 (95% CI = 0.721‐0.904, adjusted C‐index = 0.801), respectively, revealing the great predictive ability of the two nomogram models. Besides, considering the limited sample size of site‐specific GC patients with follow‐up time over 5 years, we used calibration plots and decision curves regarding 3‐year to evaluate the nomograms, the results also demonstrated the good calibration and clinical application of the two nomograms (Figure <xref rid="jcmm15618-sup-0001" ref-type="supplementary-material">S4</xref>).</p>
      <fig fig-type="FIGURE" xml:lang="en" id="jcmm15618-fig-0003" orientation="portrait" position="float">
        <label>FIGURE 3</label>
        <caption>
          <p>Nomograms that included clinical and transcriptomic prognostic factors to predict the 5‐year overall survival for site‐specific gastric cancer (GC) patients. (A) Cardia cancer; (B) non‐cardia cancer</p>
        </caption>
        <graphic id="nlm-graphic-5" xlink:href="JCMM-24-9457-g003"/>
      </fig>
    </sec>
    <sec id="jcmm15618-sec-0016">
      <label>3.5</label>
      <title>Development of GC‐SMS</title>
      <p>An online version of user‐friendly GC site‐specific web server can be accessed at <ext-link ext-link-type="uri" xlink:href="https://njmu-zhanglab.shinyapps.io/gc_sms/">https://njmu‐zhanglab.shinyapps.io/gc_sms/</ext-link> (Figure <xref rid="jcmm15618-sup-0001" ref-type="supplementary-material">S5</xref>). Users could perform differential expression analysis and survival analysis for each biomarker simply at different GC sites by clicking the corresponding module (Figure <xref rid="jcmm15618-sup-0001" ref-type="supplementary-material">S5</xref>A). For example, the user can select a database (gene, miRNA or lncRNA) and a site (overall, cardia or non‐cardia), and input a molecular biomarker (eg <italic>ASB5</italic> for gene, AL627309.1 for lncRNA or miR‐100 for miRNA) to search the results of differential expression analysis and survival analysis. In addition, online implementation of cardia and non‐cardia GC nomogram prognostic models were also available (Figure <xref rid="jcmm15618-sup-0001" ref-type="supplementary-material">S5</xref>B), predicted 5‐year survival probability can be easily calculated by inputting clinical characteristics and expression value of site‐specific biomarkers.</p>
    </sec>
  </sec>
  <sec sec-type="discussion" id="jcmm15618-sec-0017">
    <label>4</label>
    <title>DISCUSSION</title>
    <p>GC is a heterogeneous tumour with great differences of epidemiologic and clinicopathologic features between cardia cancer and non‐cardia cancer.<xref rid="jcmm15618-bib-0012" ref-type="ref"><sup>12</sup></xref> For instance, <italic>Helicobacter pylori</italic> infection was demonstrated to be a risk factor for non‐cardia cancer, but not for cardia cancer.<xref rid="jcmm15618-bib-0013" ref-type="ref"><sup>13</sup></xref> The survival rate of cardia cancer patients was significantly lower than that of non‐cardia cancer patients.<xref rid="jcmm15618-bib-0005" ref-type="ref"><sup>5</sup></xref> However, few studies were performed to construct site‐specific GC prognostic models to predict the survival probability of cardia and non‐cardia GC patients. In this study, we applied GA‐SVM and GA‐Cox methods to identify 10 cardia‐ and 13 non–cardia‐specific GC prognostic factors, which may be useful for cardia cancer and non‐cardia cancer survival prediction.</p>
    <p>With the development of high‐throughput sequence technology, finding accurate biomarkers in high‐dimensional omics data are challenging. GA process, including natural selection, crossover and mutation, is a heuristic algorithm used to explore an optimal solution to a complex problem (such as non‐linear condition).<xref rid="jcmm15618-bib-0014" ref-type="ref"><sup>14</sup></xref>, <xref rid="jcmm15618-bib-0015" ref-type="ref"><sup>15</sup></xref>, <xref rid="jcmm15618-bib-0016" ref-type="ref"><sup>16</sup></xref> Several researchers have applied GA‐based machine learning methods to solve a variety of complex problems in high‐dimensional omics data.<xref rid="jcmm15618-bib-0011" ref-type="ref"><sup>11</sup></xref>, <xref rid="jcmm15618-bib-0017" ref-type="ref"><sup>17</sup></xref> Thus, this study proposed two approaches that combine SVM and Cox models with a GA to explore an optimal subset of site‐specific GC prognostic biomarkers. As a result, we finally identified 10 and 13 cardia‐ and non–cardia‐specific GC prognostic factors with a good discriminatory ability, reflecting the GA‐based algorithms’ superior performance.</p>
    <p>In the present study, the cardia cancer prognostic model was constructed using 7 genes and 3 lncRNAs; and non‐cardia cancer survival model was constructed using 10 genes, 1 lncRNA and 2 miRNAs. Among these genes, most of them have been demonstrated to be involved in several complex biological processes. For example, <italic>APAF1</italic> is a key apoptosis factor, which is closely related to several cancer‐inducing genes and tumour suppressor genes (eg <italic>p53</italic>).<xref rid="jcmm15618-bib-0018" ref-type="ref"><sup>18</sup></xref>
<italic>EN1</italic> is a transcription factor hypermethylated in multiple cancers, including colorectal cancer, prostate cancer and ovarian cancer, and has been considered as a potential biomarker for several tumours.<xref rid="jcmm15618-bib-0019" ref-type="ref"><sup>19</sup></xref>, <xref rid="jcmm15618-bib-0020" ref-type="ref"><sup>20</sup></xref>, <xref rid="jcmm15618-bib-0021" ref-type="ref"><sup>21</sup></xref>
<italic>CYP19A1</italic> has been demonstrated to be associated with the prognosis of GC.<xref rid="jcmm15618-bib-0022" ref-type="ref"><sup>22</sup></xref>
<italic>CREB3L3</italic>, cAMP‐responsive element‐binding protein 3‐like 3, is involved in the inflammatory response.<xref rid="jcmm15618-bib-0023" ref-type="ref"><sup>23</sup></xref> Several studies have demonstrated the overexpression of <italic>CTSV</italic> in multiple malignant tumours (eg breast ductal carcinoma) and was deemed as a potential prognostic biomarker.<xref rid="jcmm15618-bib-0024" ref-type="ref"><sup>24</sup></xref>
<italic>AMDHD1</italic> has been reported to be overexpressed in adrenal adenoma compared with adrenal carcinoma and is involved in the histidine metabolism pathway.<xref rid="jcmm15618-bib-0025" ref-type="ref"><sup>25</sup></xref>
<italic>NETO2</italic> was reported to be overexpressed in several cancers, including renal cancer, lung cancer and colon cancer.<xref rid="jcmm15618-bib-0026" ref-type="ref"><sup>26</sup></xref> Hu <italic>et al</italic> also found that high expression of <italic>NETO2</italic> could be considered as a potential biomarker of both advanced tumour progression and poor prognosis in colorectal cancer patients.<xref rid="jcmm15618-bib-0027" ref-type="ref"><sup>27</sup></xref> In addition to genes, miRNAs are a class of non‐coding RNA molecules that play a vital role in cell differentiation, proliferation and survival by altering the expression of multiple genes.<xref rid="jcmm15618-bib-0028" ref-type="ref"><sup>28</sup></xref> lncRNAs are a batch of long non‐coding RNA transcripts with a vital role in cancer carcinogenesis and progression.<xref rid="jcmm15618-bib-0029" ref-type="ref"><sup>29</sup></xref>, <xref rid="jcmm15618-bib-0030" ref-type="ref"><sup>30</sup></xref> Therefore, we also introduced multiple miRNAs and lncRNAs to the prognostic models for avoiding the limited predictive power of gene sets. In summary, we found that the addition of transcriptomic risk score could improve traditional prognostic models’ predictive accuracy. The discovery of transcriptomic signatures as a prognostic biomarker for cardia cancer and non‐cardia cancer has the potential to be applied in GC risk stratification and personalized therapy.</p>
    <p>There were several strengths in this study as follows: (a) this is a comprehensive study to identify the cardia‐ and non–cardia‐specific GC prognostic biomarkers using TCGA STAD transcriptomic data; (b) we proposed GA‐SVM and GA‐Cox methods to explore an optimal subset of prognostic biomarkers; (c) we constructed a combined prognostic model including clinical and transcriptomic prognostic factors, to further improve the predictive power of traditional survival prediction model; and (d) we developed a user‐friendly website to predict the survival probability of cardia and non‐cardia GC patients. In addition, some limitations needed to be noted: (a) the predictive power of transcriptomic prognostic model may be limited, future multi‐omics studies are required to improve the model performance; (b) we need to further validate the two GC prognostic models using external data; and (c) the roles of these biomarkers in influencing site‐specific GC prognosis need to be further validated by biological assays.</p>
    <p>In conclusion, based on GA‐SVM and GA‐Cox methods, we identified 23 (cardia: 10 and non‐cardia: 13) site‐specific GC prognostic biomarkers and developed two nomogram prognostic models for predicting cardia cancer and non‐cardia cancer survival, providing more support for the individualized therapy of cardia and non‐cardia GC patients.</p>
  </sec>
  <sec sec-type="COI-statement" id="jcmm15618-sec-0019">
    <title>CONFLICTS OF INTEREST</title>
    <p>The authors have declared no conflicts of interest.</p>
  </sec>
  <sec id="jcmm15618-sec-0020">
    <title>AUTHOR CONTRIBUTION</title>
    <p><bold>Junyi Xin:</bold> Conceptualization (equal); Formal analysis (equal); Methodology (equal); Writing‐original draft (equal); Writing‐review &amp; editing (equal). <bold>Yanling Wu:</bold> Formal analysis (equal); Methodology (equal); Writing‐review &amp; editing (equal). <bold>Xiaowei Wang:</bold> Formal analysis (equal); Writing‐review &amp; editing (equal). <bold>Shuwei Li:</bold> Data curation (equal); Resources (equal). <bold>Haiyan Chu:</bold> Data curation (equal); Resources (equal). <bold>Meilin Wang:</bold> Conceptualization (equal); Investigation (equal); Writing‐review &amp; editing (equal). <bold>Mulong Du:</bold> Conceptualization (equal); Investigation (equal); Project administration (equal); Supervision (equal); Writing‐review &amp; editing (equal). <bold>Zhengdong Zhang:</bold> Conceptualization (equal); Funding acquisition (equal); Project administration (equal); Supervision (equal); Writing‐review &amp; editing (equal).</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supporting information</title>
    <supplementary-material content-type="local-data" id="jcmm15618-sup-0001">
      <caption>
        <p>Appendix S1</p>
      </caption>
      <media xlink:href="JCMM-24-9457-s001.docx">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <ack id="jcmm15618-sec-0018">
    <title>ACKNOWLEDGEMENTS</title>
    <p>We thank the Cancer Genome Atlas (TCGA) for sharing the transcriptomic database.</p>
  </ack>
  <sec sec-type="data-availability" id="jcmm15618-sec-0022">
    <title>DATA AVAILABILITY STATEMENT</title>
    <p>All data will be made available upon request.</p>
  </sec>
  <ref-list content-type="cited-references" id="jcmm15618-bibl-0001">
    <title>REFERENCES</title>
    <ref id="jcmm15618-bib-0001">
      <label>1</label>
      <mixed-citation publication-type="journal" id="jcmm15618-cit-0001"><string-name><surname>Bray</surname><given-names>F</given-names></string-name>, <string-name><surname>Ferlay</surname><given-names>J</given-names></string-name>, <string-name><surname>Soerjomataram</surname><given-names>I</given-names></string-name>, et al. <article-title>Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries</article-title>. <source xml:lang="en">CA Cancer J Clin</source>. <year>2018</year>;<volume>68</volume>(<issue>6</issue>):<fpage>394</fpage>‐<lpage>424</lpage>.<pub-id pub-id-type="pmid">30207593</pub-id></mixed-citation>
    </ref>
    <ref id="jcmm15618-bib-0002">
      <label>2</label>
      <mixed-citation publication-type="journal" id="jcmm15618-cit-0002"><string-name><surname>Colquhoun</surname><given-names>A</given-names></string-name>, <string-name><surname>Arnold</surname><given-names>M</given-names></string-name>, <string-name><surname>Ferlay</surname><given-names>J</given-names></string-name>, et al. <article-title>Global patterns of cardia and non‐cardia gastric cancer incidence in 2012</article-title>. <source xml:lang="en">Gut</source>. <year>2015</year>;<volume>64</volume>(<issue>12</issue>):<fpage>1881</fpage>‐<lpage>1888</lpage>.<pub-id pub-id-type="pmid">25748648</pub-id></mixed-citation>
    </ref>
    <ref id="jcmm15618-bib-0003">
      <label>3</label>
      <mixed-citation publication-type="journal" id="jcmm15618-cit-0003"><string-name><surname>Cavaleiro‐Pinto</surname><given-names>M</given-names></string-name>, <string-name><surname>Peleteiro</surname><given-names>B</given-names></string-name>, <string-name><surname>Lunet</surname><given-names>N</given-names></string-name>, et al. <article-title>Helicobacter pylori infection and gastric cardia cancer: systematic review and meta‐analysis</article-title>. <source xml:lang="en">Cancer Causes Control</source>. <year>2011</year>;<volume>22</volume>(<issue>3</issue>):<fpage>375</fpage>‐<lpage>387</lpage>.<pub-id pub-id-type="pmid">21184266</pub-id></mixed-citation>
    </ref>
    <ref id="jcmm15618-bib-0004">
      <label>4</label>
      <mixed-citation publication-type="journal" id="jcmm15618-cit-0004"><string-name><surname>Zeng</surname><given-names>H</given-names></string-name>, <string-name><surname>Chen</surname><given-names>W</given-names></string-name>, <string-name><surname>Zheng</surname><given-names>R</given-names></string-name>, et al. <article-title>Changing cancer survival in China during 2003–15: a pooled analysis of 17 population‐based cancer registries</article-title>. <source xml:lang="en">Lancet Glob Health</source>. <year>2018</year>;<volume>6</volume>(<issue>5</issue>):<fpage>e555</fpage>‐<lpage>e567</lpage>.<pub-id pub-id-type="pmid">29653628</pub-id></mixed-citation>
    </ref>
    <ref id="jcmm15618-bib-0005">
      <label>5</label>
      <mixed-citation publication-type="journal" id="jcmm15618-cit-0005"><string-name><surname>Park</surname><given-names>JC</given-names></string-name>, <string-name><surname>Lee</surname><given-names>YC</given-names></string-name>, <string-name><surname>Kim</surname><given-names>JH</given-names></string-name>, et al. <article-title>Clinicopathological features and prognostic factors of proximal gastric carcinoma in a population with high <italic>Helicobacter pylori</italic> prevalence: a single‐center, large‐volume study in Korea</article-title>. <source xml:lang="en">Ann Surg Oncol</source>. <year>2010</year>;<volume>17</volume>(<issue>3</issue>):<fpage>829</fpage>‐<lpage>837</lpage>.<pub-id pub-id-type="pmid">19882188</pub-id></mixed-citation>
    </ref>
    <ref id="jcmm15618-bib-0006">
      <label>6</label>
      <mixed-citation publication-type="journal" id="jcmm15618-cit-0006"><string-name><surname>Zhao</surname><given-names>J</given-names></string-name>, <string-name><surname>Zhao</surname><given-names>J</given-names></string-name>, <string-name><surname>Du</surname><given-names>F</given-names></string-name>, et al. <article-title>Cardia and non‐cardia gastric cancer have similar stage‐for‐stage prognoses after R0 resection: a large‐scale, Multicenter Study in China</article-title>. <source xml:lang="en">J Gastrointest Surg</source>. <year>2016</year>;<volume>20</volume>(<issue>4</issue>):<fpage>700</fpage>‐<lpage>707</lpage>.<pub-id pub-id-type="pmid">26831062</pub-id></mixed-citation>
    </ref>
    <ref id="jcmm15618-bib-0007">
      <label>7</label>
      <mixed-citation publication-type="journal" id="jcmm15618-cit-0007"><string-name><surname>Zhu</surname><given-names>X</given-names></string-name>, <string-name><surname>Tian</surname><given-names>X</given-names></string-name>, <string-name><surname>Sun</surname><given-names>T</given-names></string-name>, et al. <article-title>GeneExpressScore signature: a robust prognostic and predictive classifier in gastric cancer</article-title>. <source xml:lang="en">Mol Oncol</source>. <year>2018</year>;<volume>12</volume>(<issue>11</issue>):<fpage>1871</fpage>‐<lpage>1883</lpage>.<pub-id pub-id-type="pmid">29957874</pub-id></mixed-citation>
    </ref>
    <ref id="jcmm15618-bib-0008">
      <label>8</label>
      <mixed-citation publication-type="journal" id="jcmm15618-cit-0008"><string-name><surname>Zheng</surname><given-names>L</given-names></string-name>, <string-name><surname>Wang</surname><given-names>L</given-names></string-name>, <string-name><surname>Ajani</surname><given-names>J</given-names></string-name>, et al. <article-title>Molecular basis of gastric cancer development and progression</article-title>. <source xml:lang="en">Gastric Cancer</source>. <year>2004</year>;<volume>7</volume>(<issue>2</issue>):<fpage>61</fpage>‐<lpage>77</lpage>.<pub-id pub-id-type="pmid">15224192</pub-id></mixed-citation>
    </ref>
    <ref id="jcmm15618-bib-0009">
      <label>9</label>
      <mixed-citation publication-type="journal" id="jcmm15618-cit-0009"><string-name><surname>Burke</surname><given-names>DS</given-names></string-name>, <string-name><surname>De Jong</surname><given-names>KA</given-names></string-name>, <string-name><surname>Grefenstette</surname><given-names>JJ</given-names></string-name>, et al. <article-title>Putting more genetics into genetic algorithms</article-title>. <source xml:lang="en">Evol Comput</source>. <year>1998</year>;<volume>6</volume>(<issue>4</issue>):<fpage>387</fpage>‐<lpage>410</lpage>.<pub-id pub-id-type="pmid">10030470</pub-id></mixed-citation>
    </ref>
    <ref id="jcmm15618-bib-0010">
      <label>10</label>
      <mixed-citation publication-type="journal" id="jcmm15618-cit-0010"><string-name><surname>Paul</surname><given-names>D</given-names></string-name>, <string-name><surname>Su</surname><given-names>R</given-names></string-name>, <string-name><surname>Romain</surname><given-names>M</given-names></string-name>, et al. <article-title>Feature selection for outcome prediction in oesophageal cancer using genetic algorithm and random forest classifier</article-title>. <source xml:lang="en">Comput Med Imaging Graph</source>. <year>2017</year>;<volume>60</volume>:<fpage>42</fpage>‐<lpage>49</lpage>.<pub-id pub-id-type="pmid">28087102</pub-id></mixed-citation>
    </ref>
    <ref id="jcmm15618-bib-0011">
      <label>11</label>
      <mixed-citation publication-type="journal" id="jcmm15618-cit-0011"><string-name><surname>Saini</surname><given-names>H</given-names></string-name>, <string-name><surname>Lal</surname><given-names>SP</given-names></string-name>, <string-name><surname>Naidu</surname><given-names>VV</given-names></string-name>, et al. <article-title>Gene masking – a technique to improve accuracy for cancer classification with high dimensionality in microarray data</article-title>. <source xml:lang="en">BMC Med Genomics</source>. <year>2016</year>;<volume>9</volume>(<issue>Suppl 3</issue>):<fpage>74</fpage>.<pub-id pub-id-type="pmid">28117659</pub-id></mixed-citation>
    </ref>
    <ref id="jcmm15618-bib-0012">
      <label>12</label>
      <mixed-citation publication-type="journal" id="jcmm15618-cit-0012"><string-name><surname>Kamangar</surname><given-names>F</given-names></string-name>, <string-name><surname>Qiao</surname><given-names>YL</given-names></string-name>, <string-name><surname>Blaser</surname><given-names>MJ</given-names></string-name>, et al. <article-title>Helicobacter pylori and oesophageal and gastric cancers in a prospective study in China</article-title>. <source xml:lang="en">Br J Cancer</source>. <year>2007</year>;<volume>96</volume>(<issue>1</issue>):<fpage>172</fpage>‐<lpage>176</lpage>.<pub-id pub-id-type="pmid">17179990</pub-id></mixed-citation>
    </ref>
    <ref id="jcmm15618-bib-0013">
      <label>13</label>
      <mixed-citation publication-type="journal" id="jcmm15618-cit-0013"><string-name><surname>Plummer</surname><given-names>M</given-names></string-name>, <string-name><surname>Franceschi</surname><given-names>S</given-names></string-name>, <string-name><surname>Vignat</surname><given-names>J</given-names></string-name>, et al. <article-title>Global burden of gastric cancer attributable to <italic>Helicobacter pylori</italic>
</article-title>. <source xml:lang="en">Int J Cancer</source>. <year>2015</year>;<volume>136</volume>(<issue>2</issue>):<fpage>487</fpage>‐<lpage>490</lpage>.<pub-id pub-id-type="pmid">24889903</pub-id></mixed-citation>
    </ref>
    <ref id="jcmm15618-bib-0014">
      <label>14</label>
      <mixed-citation publication-type="journal" id="jcmm15618-cit-0014"><string-name><surname>Manning</surname><given-names>T</given-names></string-name>, <string-name><surname>Sleator</surname><given-names>RD</given-names></string-name>, <string-name><surname>Walsh</surname><given-names>P</given-names></string-name>. <article-title>Naturally selecting solutions: the use of genetic algorithms in bioinformatics</article-title>. <source xml:lang="en">Bioengineered</source>. <year>2013</year>;<volume>4</volume>(<issue>5</issue>):<fpage>266</fpage>‐<lpage>278</lpage>.<pub-id pub-id-type="pmid">23222169</pub-id></mixed-citation>
    </ref>
    <ref id="jcmm15618-bib-0015">
      <label>15</label>
      <mixed-citation publication-type="journal" id="jcmm15618-cit-0015"><string-name><surname>Pena‐Malavera</surname><given-names>A</given-names></string-name>, <string-name><surname>Bruno</surname><given-names>C</given-names></string-name>, <string-name><surname>Fernandez</surname><given-names>E</given-names></string-name>, et al. <article-title>Comparison of algorithms to infer genetic population structure from unlinked molecular markers</article-title>. <source xml:lang="en">Stat Appl Genet Mol Biol</source>. <year>2014</year>;<volume>13</volume>(<issue>4</issue>):<fpage>391</fpage>‐<lpage>402</lpage>.<pub-id pub-id-type="pmid">24964261</pub-id></mixed-citation>
    </ref>
    <ref id="jcmm15618-bib-0016">
      <label>16</label>
      <mixed-citation publication-type="journal" id="jcmm15618-cit-0016"><string-name><surname>Su</surname><given-names>F</given-names></string-name>, <string-name><surname>Yuan</surname><given-names>P</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Y</given-names></string-name>, et al. <article-title>The superior fault tolerance of artificial neural network training with a fault/noise injection‐based genetic algorithm</article-title>. <source xml:lang="en">Protein Cell</source>. <year>2016</year>;<volume>7</volume>(<issue>10</issue>):<fpage>735</fpage>‐<lpage>748</lpage>.<pub-id pub-id-type="pmid">27502185</pub-id></mixed-citation>
    </ref>
    <ref id="jcmm15618-bib-0017">
      <label>17</label>
      <mixed-citation publication-type="journal" id="jcmm15618-cit-0017"><string-name><surname>Chowdhury</surname><given-names>B</given-names></string-name>, <string-name><surname>Garai</surname><given-names>A</given-names></string-name>, <string-name><surname>Garai</surname><given-names>G</given-names></string-name>. <article-title>An optimized approach for annotation of large eukaryotic genomic sequences using genetic algorithm</article-title>. <source xml:lang="en">BMC Bioinformatics</source>. <year>2017</year>;<volume>18</volume>(<issue>1</issue>):<fpage>460</fpage>.<pub-id pub-id-type="pmid">29065853</pub-id></mixed-citation>
    </ref>
    <ref id="jcmm15618-bib-0018">
      <label>18</label>
      <mixed-citation publication-type="journal" id="jcmm15618-cit-0018"><string-name><surname>Sturm</surname><given-names>I</given-names></string-name>, <string-name><surname>Bosanquet</surname><given-names>AG</given-names></string-name>, <string-name><surname>Radetzki</surname><given-names>S</given-names></string-name>, et al. <article-title>Silencing of APAF‐1 in B‐CLL results in poor prognosis in the case of concomitant p53 mutation</article-title>. <source xml:lang="en">Int J Cancer</source>. <year>2006</year>;<volume>118</volume>(<issue>9</issue>):<fpage>2329</fpage>‐<lpage>2336</lpage>.<pub-id pub-id-type="pmid">16331630</pub-id></mixed-citation>
    </ref>
    <ref id="jcmm15618-bib-0019">
      <label>19</label>
      <mixed-citation publication-type="journal" id="jcmm15618-cit-0019"><string-name><surname>Frigola</surname><given-names>J</given-names></string-name>, <string-name><surname>Song</surname><given-names>J</given-names></string-name>, <string-name><surname>Stirzaker</surname><given-names>C</given-names></string-name>, et al. <article-title>Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome band</article-title>. <source xml:lang="en">Nat Genet</source>. <year>2006</year>;<volume>38</volume>(<issue>5</issue>):<fpage>540</fpage>‐<lpage>549</lpage>.<pub-id pub-id-type="pmid">16642018</pub-id></mixed-citation>
    </ref>
    <ref id="jcmm15618-bib-0020">
      <label>20</label>
      <mixed-citation publication-type="journal" id="jcmm15618-cit-0020"><string-name><surname>Devaney</surname><given-names>J</given-names></string-name>, <string-name><surname>Stirzaker</surname><given-names>C</given-names></string-name>, <string-name><surname>Qu</surname><given-names>W</given-names></string-name>, et al. <article-title>Epigenetic deregulation across chromosome 2q14.2 differentiates normal from prostate cancer and provides a regional panel of novel DNA methylation cancer biomarkers</article-title>. <source xml:lang="en">Cancer Epidemiol Biomarkers Prev</source>. <year>2011</year>;<volume>20</volume>(<issue>1</issue>):<fpage>148</fpage>‐<lpage>159</lpage>.<pub-id pub-id-type="pmid">21098650</pub-id></mixed-citation>
    </ref>
    <ref id="jcmm15618-bib-0021">
      <label>21</label>
      <mixed-citation publication-type="journal" id="jcmm15618-cit-0021"><string-name><surname>Montavon</surname><given-names>C</given-names></string-name>, <string-name><surname>Gloss</surname><given-names>BS</given-names></string-name>, <string-name><surname>Warton</surname><given-names>K</given-names></string-name>, et al. <article-title>Prognostic and diagnostic significance of DNA methylation patterns in high grade serous ovarian cancer</article-title>. <source xml:lang="en">Gynecol Oncol</source>. <year>2012</year>;<volume>124</volume>(<issue>3</issue>):<fpage>582</fpage>‐<lpage>588</lpage>.<pub-id pub-id-type="pmid">22115852</pub-id></mixed-citation>
    </ref>
    <ref id="jcmm15618-bib-0022">
      <label>22</label>
      <mixed-citation publication-type="journal" id="jcmm15618-cit-0022"><string-name><surname>Yang</surname><given-names>JC</given-names></string-name>, <string-name><surname>Chang</surname><given-names>N</given-names></string-name>, <string-name><surname>Wu</surname><given-names>DC</given-names></string-name>, et al. <article-title>Preclinical evaluation of exemestane as a novel chemotherapy for gastric cancer</article-title>. <source xml:lang="en">J Cell Mol Med</source>. <year>2019</year>;<volume>23</volume>(<issue>11</issue>):<fpage>7417</fpage>‐<lpage>7426</lpage>.<pub-id pub-id-type="pmid">31557413</pub-id></mixed-citation>
    </ref>
    <ref id="jcmm15618-bib-0023">
      <label>23</label>
      <mixed-citation publication-type="journal" id="jcmm15618-cit-0023"><string-name><surname>Chin</surname><given-names>KT</given-names></string-name>, <string-name><surname>Zhou</surname><given-names>HJ</given-names></string-name>, <string-name><surname>Wong</surname><given-names>CM</given-names></string-name>, et al. <article-title>The liver‐enriched transcription factor CREB‐H is a growth suppressor protein underexpressed in hepatocellular carcinoma</article-title>. <source xml:lang="en">Nucleic Acids Res</source>. <year>2005</year>;<volume>33</volume>(<issue>6</issue>):<fpage>1859</fpage>‐<lpage>1873</lpage>.<pub-id pub-id-type="pmid">15800215</pub-id></mixed-citation>
    </ref>
    <ref id="jcmm15618-bib-0024">
      <label>24</label>
      <mixed-citation publication-type="journal" id="jcmm15618-cit-0024"><string-name><surname>Toss</surname><given-names>M</given-names></string-name>, <string-name><surname>Miligy</surname><given-names>I</given-names></string-name>, <string-name><surname>Gorringe</surname><given-names>K</given-names></string-name>, et al. <article-title>Prognostic significance of cathepsin V (CTSV/CTSL2) in breast ductal carcinoma in situ</article-title>. <source xml:lang="en">J Clin Pathol</source>. <year>2020</year>;<volume>73</volume>(<issue>2</issue>):<fpage>76</fpage>‐<lpage>82</lpage>.<pub-id pub-id-type="pmid">31444238</pub-id></mixed-citation>
    </ref>
    <ref id="jcmm15618-bib-0025">
      <label>25</label>
      <mixed-citation publication-type="journal" id="jcmm15618-cit-0025"><string-name><surname>Assie</surname><given-names>G</given-names></string-name>, <string-name><surname>Guillaud‐Bataille</surname><given-names>M</given-names></string-name>, <string-name><surname>Ragazzon</surname><given-names>B</given-names></string-name>, et al. <article-title>The pathophysiology, diagnosis and prognosis of adrenocortical tumors revisited by transcriptome analyses</article-title>. <source xml:lang="en">Trends Endocrinol Metab</source>. <year>2010</year>;<volume>21</volume>(<issue>5</issue>):<fpage>325</fpage>‐<lpage>334</lpage>.<pub-id pub-id-type="pmid">20097573</pub-id></mixed-citation>
    </ref>
    <ref id="jcmm15618-bib-0026">
      <label>26</label>
      <mixed-citation publication-type="journal" id="jcmm15618-cit-0026"><string-name><surname>Oparina</surname><given-names>N</given-names></string-name>, <string-name><surname>Sadritdinova</surname><given-names>AF</given-names></string-name>, <string-name><surname>Snezhkina</surname><given-names>AV</given-names></string-name>, et al. <article-title>Increase in NETO2 gene expression is a potential molecular genetic marker in renal and lung cancers</article-title>. <source xml:lang="en">Genetika</source>. <year>2012</year>;<volume>48</volume>(<issue>5</issue>):<fpage>599</fpage>‐<lpage>607</lpage>.<pub-id pub-id-type="pmid">22830255</pub-id></mixed-citation>
    </ref>
    <ref id="jcmm15618-bib-0027">
      <label>27</label>
      <mixed-citation publication-type="journal" id="jcmm15618-cit-0027"><string-name><surname>Hu</surname><given-names>L</given-names></string-name>, <string-name><surname>Chen</surname><given-names>HY</given-names></string-name>, <string-name><surname>Cai</surname><given-names>J</given-names></string-name>, et al. <article-title>Upregulation of NETO2 expression correlates with tumor progression and poor prognosis in colorectal carcinoma</article-title>. <source xml:lang="en">BMC Cancer</source>. <year>2015</year>;<volume>15</volume>:<fpage>1006</fpage>.<pub-id pub-id-type="pmid">26699544</pub-id></mixed-citation>
    </ref>
    <ref id="jcmm15618-bib-0028">
      <label>28</label>
      <mixed-citation publication-type="journal" id="jcmm15618-cit-0028"><string-name><surname>Bartel</surname><given-names>DP</given-names></string-name>. <article-title>MicroRNAs: genomics, biogenesis, mechanism, and function</article-title>. <source xml:lang="en">Cell</source>. <year>2004</year>;<volume>116</volume>(<issue>2</issue>):<fpage>281</fpage>‐<lpage>297</lpage>.<pub-id pub-id-type="pmid">14744438</pub-id></mixed-citation>
    </ref>
    <ref id="jcmm15618-bib-0029">
      <label>29</label>
      <mixed-citation publication-type="journal" id="jcmm15618-cit-0029"><string-name><surname>Xu</surname><given-names>MD</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Y</given-names></string-name>, <string-name><surname>Weng</surname><given-names>W</given-names></string-name>, et al. <article-title>A positive feedback loop of lncRNA‐PVT1 and FOXM1 facilitates gastric cancer growth and invasion</article-title>. <source xml:lang="en">Clin Cancer Res</source>. <year>2017</year>;<volume>23</volume>(<issue>8</issue>):<fpage>2071</fpage>‐<lpage>2080</lpage>.<pub-id pub-id-type="pmid">27756785</pub-id></mixed-citation>
    </ref>
    <ref id="jcmm15618-bib-0030">
      <label>30</label>
      <mixed-citation publication-type="journal" id="jcmm15618-cit-0030"><string-name><surname>Schmitt</surname><given-names>AM</given-names></string-name>, <string-name><surname>Chang</surname><given-names>HY</given-names></string-name>. <article-title>Long noncoding RNAs in cancer pathways</article-title>. <source xml:lang="en">Cancer Cell</source>. <year>2016</year>;<volume>29</volume>(<issue>4</issue>):<fpage>452</fpage>‐<lpage>463</lpage>.<pub-id pub-id-type="pmid">27070700</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
